Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
68.49 CHF | -1.53% | -.--% | -.--% |
May. 29 | UBS Adjusts DuPont de Nemours Price Target to $98 From $93, Maintains Buy Rating | MT |
May. 28 | DuPont's Breakup Plan Holds Logic Amid Disadvantages, BofA Says | MT |
Sales 2024 * | 12.27B 11.02B | Sales 2025 * | 12.92B 11.6B | Capitalization | 34.35B 30.85B |
---|---|---|---|---|---|
Net income 2024 * | 929M 834M | Net income 2025 * | 1.26B 1.14B | EV / Sales 2024 * | 3.24 x |
Net Debt 2024 * | 5.36B 4.81B | Net Debt 2025 * | 5.21B 4.68B | EV / Sales 2025 * | 3.06 x |
P/E ratio 2024 * |
31.3
x | P/E ratio 2025 * |
23
x | Employees | - |
Yield 2024 * |
1.85% | Yield 2025 * |
2.02% | Free-Float | 99.85% |
Latest transcript on DuPont de Nemours, Inc.
1 day | -1.53% |
Managers | Title | Age | Since |
---|---|---|---|
Edward Breen
CEO | Chief Executive Officer | 68 | 15-09-30 |
Lori Koch
DFI | Director of Finance/CFO | 49 | 02-12-31 |
Alexa Dembek
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kristina Johnson
BRD | Director/Board Member | 67 | 22-05-25 |
Luke Kissam
BRD | Director/Board Member | 59 | 19-05-31 |
Thère du Pont
BRD | Director/Board Member | 57 | 19-05-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.61% | 74.34B | |
-1.55% | 46.86B | |
+9.93% | 18.1B | |
+11.37% | 11.92B | |
-2.33% | 10.43B | |
-21.70% | 10.33B | |
-0.19% | 9.04B | |
-8.59% | 7.84B | |
-2.25% | 7.52B |
- Stock Market
- Equities
- DD Stock
- 6D81 Stock